Condition
Vitreous Detachment
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Unknown2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05249413Completed
Early Vitrectomy for Endophthalmitis After Cataract Surgery
NCT04865991Not ApplicableCompletedPrimary
Comparison of Propofol Target Controlled Infusion (TCI) and Sevoflurane
NCT04346095Phase 4Unknown
Oral Sedation in Vitreoretinal Surgery
NCT03970148Not ApplicableUnknownPrimary
YAG Laser Vitreolysis for Floaters
NCT02783209Not ApplicableTerminated
Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient
NCT00198471Phase 2CompletedPrimary
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
Showing all 6 trials